족저근막염 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Plantar Fasciitis Treatment Market size is expected to reach USD 23.86 Billion in 2034 from USD 3.50 Billion (2025) growing at a CAGR of 23.76% during 2026-2034.

The Global Plantar Fasciitis Treatment Market is expanding due to the rising incidence of foot disorders, sports injuries, and obesity-related conditions. Plantar fasciitis is a common cause of heel pain, particularly among athletes and aging populations. Growing awareness about early diagnosis and treatment options such as orthotics, physiotherapy, medications, and minimally invasive procedures is supporting market growth. Increasing participation in physical activities also contributes to higher demand for treatment solutions.

Technological advancements in diagnostic imaging and therapeutic devices are key drivers for the market. The availability of innovative treatments, including shockwave therapy and regenerative medicine, is enhancing patient outcomes. Additionally, the increasing focus on non-surgical treatment methods and improved footwear technology is positively influencing demand. Healthcare providers are emphasizing preventive care and rehabilitation programs to reduce recurrence rates.

In the future, the market is expected to witness continued growth supported by advancements in biologics and personalized treatment approaches. Expanding healthcare infrastructure in emerging economies will further accelerate adoption. Rising healthcare expenditure and insurance coverage for musculoskeletal disorders will also play a vital role. As research in pain management and tissue regeneration progresses, the plantar fasciitis treatment market is poised for sustained development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Medication Therapy
• Orthotics
• Shockwave Therapy
• Surgery
• Others

By End User

• Hospitals
• Ambulatory Surgical Center
• Clinics
• Others

COMPANIES PROFILED

• Pfizer Inc, Algeo Ltd, Otto bock SE Co, Hanger Inc, Bayer, GlaxoSmithKline Plc, Superfeet Worldwide Inc, Bauerfeid AG, KGaA Otto bock Holding, Sanofi, Group Dr Scholls
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Medication Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Orthotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Shockwave Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PLANTAR FASCIITIS TREATMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Pfizer Inc
  • 8.2.2 Algeo Ltd
  • 8.2.3 Otto Bock SE & Co
  • 8.2.4 Hanger Inc
  • 8.2.5 Bayer
  • 8.2.6 GlaxoSmithKline Plc
  • 8.2.7 Superfeet Worldwide Inc
  • 8.2.8 Bauerfeid AG
  • 8.2.9 KGaA (Otto Bock Holding)
  • 8.2.10 Sanofi
  • 8.2.11 Group (Dr. Scholl'S)